---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-018167"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:30:31.728896+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Abbott reduces board size from 13 to 12 directors effective April 24, 2026

## Summary
- Board of Directors amended Article III, Section 2 of By-Laws on February 20, 2026.
- Board size reduced from 13 to 12 persons, effective April 24, 2026.
- Amended By-Laws filed as Exhibit 3.1 to the Form 8-K.

## SEC filing metadata
- accession: 0001104659-26-018167
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/0001104659-26-018167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/tm266807d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-018167
- JSON: https://secwatch.observer/filing/0001104659-26-018167.json
- Plain text: https://secwatch.observer/filing/0001104659-26-018167.txt

## Source-grounded claims
- claim_id: 620a55efc493d678873bdc82a6927ca0540a7909
  claim: ABBOTT LABORATORIES: Board reduced from thirteen to twelve members, effective April 24, 2026 (effective 2026-04-24).
  evidence_excerpt: On February 20, 2026, Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s By-Laws to provide that Abbott’s Board of Directors shall consist of twelve persons, effective April 24, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/0001104659-26-018167-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.